NovMetaPharma Co., Ltd. (XKON:229500)
South Korea · Delayed Price · Currency is KRW 3,570.00
-210.00 (-5.56%)
At close: Nov 6, 2026
NovMetaPharma Market Cap
NovMetaPharma has a market cap or net worth of 45.84 billion as of November 5, 2026. It is the 32,368th most valuable company in the world and the 1,803rd biggest in South Korea. Its market cap has decreased by 71.89% in one year.
Market Cap
45.84B
Enterprise Value
n/a
Revenue
1.30B
Global Rank
Country Rank
#1,803 South Korea
PE Ratio
29.75
ChartMarket Cap Chart
Since April 5, 2017, NovMetaPharma's market cap has decreased from 74.59B to 45.84B, a decrease of -38.54%. That is a compound annual growth rate of -4.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 45.84B | -71.99% |
| Dec 30, 2025 | 163.69B | 187.16% |
| Dec 30, 2024 | 57.00B | -46.33% |
| Dec 29, 2022 | 106.21B | -45.89% |
| Dec 30, 2021 | 196.29B | -9.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SunBio,Inc. | 62.53B |
| ABION | 60.91B |
| IMGT Co.,Ltd. | 57.82B |
| PanGen Biotech | 54.13B |
| TegoScience | 53.72B |
| Psomagen | 52.90B |
| KoBioLabs | 50.78B |
| QuadMedicine | 48.22B |